Sutro Biopharma Presents Data from Dose-Optimization Portion of REFRαME-O1 Trial in …

The SGO Annual Meeting will take place from March 14-17, 2025 in Seattle, Washington. In this study, luvelta demonstrated encouraging antitumor …

Do you trust this headline?

Based on recent headline ratings, 100% of this readership currently trusts the local media, which has an average score of 83% regionally and is currently trending positive.

100%

Media Trust Score